GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nuformix PLC (FRA:1RT) » Definitions » YoY EPS Growth

Nuformix (FRA:1RT) YoY EPS Growth : -400.00% (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Nuformix YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Nuformix's YoY EPS Growth for the quarter that ended in Sep. 2024 was -400.00%.

Nuformix's Earnings per Share (Diluted) for the six months ended in Sep. 2024 was €-0.01.

Nuformix YoY EPS Growth Historical Data

The historical data trend for Nuformix's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nuformix YoY EPS Growth Chart

Nuformix Annual Data
Trend Dec15 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Sep24
YoY EPS Growth
Get a 7-Day Free Trial Premium Member Only 50.00 -50.00 33.33 50.00 -400.00

Nuformix Semi-Annual Data
Dec15 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Mar24 Sep24
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 100.00 -400.00

Nuformix YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Nuformix's YoY EPS Growth for the fiscal year that ended in Sep. 2024 is calculated as:

YoY EPS Growth (A: Sep. 2024 )
=(Earnings per Share (Diluted) (A: Sep. 2024 )-Earnings per Share (Diluted) (A: Mar. 2023 ))/ | Earnings per Share (Diluted) (A: Mar. 2023 ) |
=(-0.005--0.001)/ | -0.001 |
=-400.00 %

Nuformix's YoY EPS Growth for the quarter that ended in Sep. 2024 is calculated as:

YoY EPS Growth (Q: Sep. 2024 )
=(Earnings per Share (Diluted) (Q: Sep. 2024 )-Earnings per Share (Diluted) (Q: Mar. 2023 )) / | Earnings per Share (Diluted) (Q: Mar. 2023 )) |
=(-0.005--0.001)/ | -0.001 |
=-400.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nuformix YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Nuformix's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Nuformix Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nuformix PLC (FRA:1RT) » Definitions » YoY EPS Growth
Comparable Companies
LSE:BSFA LSE:PYC LSE:VAL LSE:ONC LSE:ROQ LSE:CRTX LSE:GENF LSE:TCF LSE:APTA AQSE:INC VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
NFX:UK 1RT:Germany
Address
60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR
Website
https://www.nuformix.com
Nuformix PLC is a pharmaceutical development company. It operates in the field of pharmaceutical development targeting unmet medical needs in fibrosis and oncology via drug repurposing. Its pipeline products include NXP001, NXP002, and NXP004. Geographically, the company operates only in the UK.

Nuformix Headlines

No Headlines